CMS officialised the appointment of Florian Schönknecht (pictured) — former head investigations at FINMA — as a partner effective February 1st 2026. The profile An expert in the areas of investigations, compliance and financial market law, Schö
Tags :dx1
Baker McKenzie advised SFP Investment Foundation on all legal and tax aspects, and Copré on the tax aspects in connection with the establishment of a new, single-investor investment group for Copré, managed by SFP investment
Vischer advised Oncobit as the Swiss specialist in precision oncology entered a strategic partnership with ID Solutions, a French company specialising in oncologic diagnostic solutions. The two companies aim at developing a new generation of
Lenz & Staehelin advised Veeam Software — a portfolio company of Insight Partners specialised in the development of data backup, data recovery and data protection solutions — in connection with its acquisition of Object First, a provider
Digital media company DAAily platforms completed the sale of Architonic, a globally active design inspiration platform for architects and designers, to Sandow Companies. Baker McKenzie Switzerland — together with lawyers from Baker McKenzie Deutschland — advised the
Baker McKenzie Switzerland advised Swiss Finance & Property Group, as the Zurich-based company acquired a real estate portfolio of seventeen properties across Switzerland for the SF Retail Properties Fund. The transaction comes after a capital
SIX-listed Santhera Pharmaceuticals has signed an exclusive licensing agreement with biopharma company Nxera Pharma for the development, manufacturing and commercialisation across Japan, South Korea, Australia and New Zealand of Agamree, a prescription medicine used to
Homburger advised Yoda PLC, an investment corporation with headquarters in Cyprus, in connection with a new CHF 100 m common bond loan issued by luxury real estate company Ultima Capital and subscribed for by National Bank
With the start of the new year, Homburger formalised the appointment of three new partners: Reto Ferrari-Visca (pictured centre), Jeremy Reichlin (pictured left), and Alexander Wherlock (pictured right). Reto Ferrari-Visca Reto Ferrari-Visca represents clients across
Homburger advised Windward Bio Group — a Swiss-based biotechnology specialist in advanced immunological diseases — in connection with a licensing agreement between the company’s affiliate, LE2025 Therapeutics, and Qyuns Therapeutics Co. for the development
